LGNDZ

(LGNDZ)

About (LGNDZ)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Details

Daily high
$0.01
Daily low
$0.01
Price at open
$0.01
52 Week High
$0.02
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
5,950
Avg. volume
210
P/E ratio
--

News

Details

Daily high
$0.01
Daily low
$0.01
Price at open
$0.01
52 Week High
$0.02
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
5,950
Avg. volume
210
P/E ratio
--